| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 02/12/2008 | US7329658 Cannabinoid receptor ligands and uses thereof |
| 02/12/2008 | US7329657 Indazolyl-substituted pyrroline compounds as kinase inhibitors |
| 02/12/2008 | US7329651 Cannabimimetic ligands |
| 02/12/2008 | US7329510 Containing specific DNA sequence; use in the therapy of disorders selected from human psychiatric and neurological disroders, cardiiovascular disorder, and reproductive dysfunction |
| 02/12/2008 | US7329499 Use of a novel human ULIP6/CRMP protein in diagnosis of paraneoplastic neurological syndromes |
| 02/12/2008 | CA2303432C Modulation of drug loading in multivesicular liposomes |
| 02/12/2008 | CA2260863C Treatment of psychotic disorders |
| 02/12/2008 | CA2227695C Furopyridine, thienopyridine, pyrrolopyridine and related pyrimidine, pyridazine and triazine compounds useful in controlling chemical synaptic transmission |
| 02/12/2008 | CA2219736C Device for transdermal electrotransport delivery of fentanyl and sufentanil |
| 02/12/2008 | CA2203246C Alk-7 (activin like kinase), a serine threonine kinase receptor |
| 02/12/2008 | CA2133982C Ligand for the c-kit receptor and methods of use thereof |
| 02/07/2008 | WO2008017000A2 Methods and pharmaceutical preparations for contributing to the treatment of chemotherapy-induced neuropathy |
| 02/07/2008 | WO2008016973A1 2,4-diaminoquinazolines for spinal muscular atrophy |
| 02/07/2008 | WO2008016913A1 Biologically potent analogues of the dmt-tic pharmacophore and methods of use |
| 02/07/2008 | WO2008016704A1 6-carboxy-normorphinan derivatives, synthesis and uses thereof |
| 02/07/2008 | WO2008016677A2 Preparation and utility of deuterated amphetamines |
| 02/07/2008 | WO2008016674A1 Agonists of the sphingosine- 1- phosphate receptor (slp) |
| 02/07/2008 | WO2008016661A2 Morpholino compounds for treating inflammatory and demyelinating diseases and cancers |
| 02/07/2008 | WO2008016175A1 Activator for peroxisome proliferator activated receptor |
| 02/07/2008 | WO2008016132A1 Benzyl phenyl glucopyranoside derivative |
| 02/07/2008 | WO2008016131A1 Fused heterocyclic compound |
| 02/07/2008 | WO2008016118A1 Agent targeting dopamine receptor and screening method therefor |
| 02/07/2008 | WO2008016077A1 Adhesive preparation |
| 02/07/2008 | WO2008016002A1 AMYLOID β PRODUCTION REGULATOR CONTAINING PROTON PUMP INHIBITOR |
| 02/07/2008 | WO2008015942A1 Therapeutic agent for neuroblastoma, method for screening for the therapeutic agent, and method for determination of prognosis of neuroblastoma |
| 02/07/2008 | WO2008015867A1 Method for activating and stabilizing dissolved hydrogen in water |
| 02/07/2008 | WO2008015538A2 Use of diaza- and thiaza-cycloalkanediones for preventing and/or treating pain and /or migraine |
| 02/07/2008 | WO2008015516A1 Fused tricyclic heterocycles for the treatment of schizophrenia |
| 02/07/2008 | WO2008015403A1 Induction of analgesia in neuropathic pain |
| 02/07/2008 | WO2008015335A1 N-(aminoheteroaryl)-1h-indole-2-carboxamide derivatives, and preparation and therapeutic application thereof |
| 02/07/2008 | WO2008015266A1 Substituted dimethylcyclobutyl compounds, their preparation and use in medicaments |
| 02/07/2008 | WO2008015253A1 Pyrazolo[1,5-a]pyrimidines, processes, uses and compositions |
| 02/07/2008 | WO2008015241A1 Phenyl-prenyl-ether derivatives for the treatment of cognitive, neurodegenerative or neuronal diseases or disorders |
| 02/07/2008 | WO2008015202A2 Anticonvulsive pharmaceutical compositions |
| 02/07/2008 | WO2008015023A2 Use of photomedin products for preventing and/or treating neuronal dysfunctions |
| 02/07/2008 | WO2008014661A1 Tetrahydroprotoberberine compounds, their manufacture, medicinal composition and uses. |
| 02/07/2008 | WO2007143422A3 Substituted pyridyl amide compounds as modulators of the histamine h3 receptor |
| 02/07/2008 | WO2007135505A3 Veterinary pharmaceutical compositions for the treatment of pain and inflammation |
| 02/07/2008 | WO2007127375A3 Formulations containing pyridazine compounds for treating neuroinflammatory diseases |
| 02/07/2008 | WO2007124734A3 Compounds a-r-x for the manufacture of pharmaceutical preparations |
| 02/07/2008 | WO2007102074A3 Salts of quetiapine |
| 02/07/2008 | US20080033170 Novel compounds |
| 02/07/2008 | US20080033165 2-(3-(2-phenyloxazolidin-4-on-3-yl)-4-(2-styryl)-azetidin-2-on-1-yl) alkanedioic acid derivatives and corresponding alkoxyalkanoic acid derivatives; treating psychological disorders, cardiovascular disorders |
| 02/07/2008 | US20080033061 Cation conducting gabaa receptors and their use |
| 02/07/2008 | US20080033055 Low-molecular-weight alkyl esters as a replacement solvents for dimethylacetamide in the synthesis of curcumin and its demethoxy-/bisdemethoxy derivatives; fragrant esters, isobutyl acetate/ethyl butyrate; low boiling; nontoxic reagents; recoverability; cost efficiency; environmentally friendly; purity |
| 02/07/2008 | US20080033054 Process for preparing memantine hydrochloride substantially free of impurities |
| 02/07/2008 | US20080033052 Dermal anesthetic compounds |
| 02/07/2008 | US20080033051 crystallization by combining O-desmethylvenlafaxine starting material and solvent selected from ethanol, tetrahydrofuran, isopropyl alcohol, heating, dissolving, recovering; inhibits re-uptake of norepinephrine and serotonin; alternative to tricyclic anti-depressants and selective re-uptake inhibitors |
| 02/07/2008 | US20080033045 Treatment of psychiatric disorders |
| 02/07/2008 | US20080033044 Crystal form; controlled release tablet of bupropion hydrobromide for reducing the ratio of the maximum/minimum plasma bupropion hydrobromide concentration (Cmax/Cmin) while maintaining bupropion plasma levels within the therapeutic window upon administration to a patient; more stable than buproin hcl |
| 02/07/2008 | US20080033043 Modified release formulations of a bupropion salt |
| 02/07/2008 | US20080033041 Use of phenylethanolaminotetralines for preparing anxiolytic drugs |
| 02/07/2008 | US20080033038 Compositions of polyphenols and methods of use |
| 02/07/2008 | US20080033027 Drug combination pharmaceutical compositions and methods for using them |
| 02/07/2008 | US20080033022 Inhibitors of c-Jun N-terminal kinases (JNK) |
| 02/07/2008 | US20080033014 Pharmaceutical composition comprising, in combination, saredutant and a selective serotonin reuptake inhibitor or a serotonin/norepinephrine reuptake inhibitor |
| 02/07/2008 | US20080033012 Enzyme inhibitors |
| 02/07/2008 | US20080033002 Modulators of muscarinic receptors |
| 02/07/2008 | US20080032998 Pyrazolopyrimidines, a process for their preparation and their use as medicine |
| 02/07/2008 | US20080032997 (5S)-5-methyl-5-({[6-[2-(trifluoromethyl)pyrimidin-5-yl]-3,4-dihydroisoquinolin-2(1H)-yl]sulfonyl}methyl)imidazolidine-2,4-dione; asthma, rhinitis, chronic obstructive pulmonary diseases (COPD), arthritis (such as rheumatoid arthritis and osteoarthritis), atherosclerosis, cancer |
| 02/07/2008 | US20080032996 Substituted Quinazoline or Pyridopyrimidine Derivative |
| 02/07/2008 | US20080032995 Aldh-2 inhibitors in the treatment of drug addiction |
| 02/07/2008 | US20080032981 Aryl n-cyanoguanidines and methods related thereto |
| 02/07/2008 | US20080032977 Alkyne-substituted pyridone compounds and methods of use |
| 02/07/2008 | US20080032975 Substituted Fused Pyrroleoximes and Fused Pyrazoleoximes |
| 02/07/2008 | US20080032971 8-heteroarylpurine mnk2 inhibitors for treating metabolic disorders |
| 02/07/2008 | US20080032969 Novel compounds |
| 02/07/2008 | US20080032965 Method for enhancing cognitive function |
| 02/07/2008 | US20080032959 Estrogen Receptor Modulators |
| 02/07/2008 | US20080032956 2-Ethyl and 2-Ethylidene-19-Nor-Vitamin D Compounds |
| 02/07/2008 | US20080032951 Ophthalmic Compositions For Treating Ocular Hypertension |
| 02/07/2008 | US20080032950 Neurologically-Active Compounds |
| 02/07/2008 | US20080032942 double-stranded (siNA) molecule that down-regulates expression of a beta-secretase (BACE) gene |
| 02/07/2008 | US20080032922 Plurality of isolated erythropoietin-like molecules; reperfusion injuries; antiischemic, antihypoxic, antiinflammatory gents; neurodegenerative or nervous system disorders; genetic engineering and expression |
| 02/07/2008 | US20080032320 Method of Screening Compound Capable of Accelerating or Inhibiting Apoptosis, Apoptosis Accelarator and Apoptosis Inhibitor |
| 02/07/2008 | US20080032314 Use of VEGF and homologuest to treat neuron disorders |
| 02/07/2008 | US20080031963 Method of treating pain by administering 24 hour oral opioid formulations exhibiting rapid rate of initial rise of plasma drug level |
| 02/07/2008 | US20080031959 Anti-migraine oral spray formulations and methods |
| 02/07/2008 | US20080031953 Composition And Method For Treating Or Preventing Psychiatric Symptom |
| 02/07/2008 | US20080031948 admixed with hydroxyalkylcellulose, polyvinylacetate, blends of polyvinylacetate and polyvinylpyrrolidone, a vinylpyrrolidone copolymer and polyethylene oxide; enteric coating |
| 02/07/2008 | US20080031935 Cholinesterase Inhibitors In Liposomes And Their Production And Use |
| 02/07/2008 | US20080031933 Transparent transdermal nicotine delivery devices |
| 02/07/2008 | US20080031875 Treatment method |
| 02/07/2008 | US20080031871 Memory and learning impairments associated with disruption of Ephrin receptor A6 (EphA6) gene |
| 02/07/2008 | US20080031870 Method of proliferation in neurogenic regions |
| 02/07/2008 | US20080031869 Pain relief composition |
| 02/07/2008 | US20080031859 Central nervous system neural progenitor cell which induces synapse-forming neurons in the spinal cord |
| 02/07/2008 | US20080031851 Using a reovirus and chemotherapeutic agents to treat ras-activated neoplastic cells; proliferative disorders |
| 02/07/2008 | DE102006038224A1 Procedure for the determination of neuroendocrinal health disorders such as e.g. chronic fatigue syndrome, comprises measuring glucocorticoids, sex steroids and amino acids/neurotransmitter and/or their metabolites in body fluids |
| 02/07/2008 | CA2660028A1 Substituted dimethylcyclobutyl compounds, their preparation and use in medicaments |
| 02/07/2008 | CA2660027A1 6-carboxy-normorphinan derivatives, synthesis and uses thereof |
| 02/07/2008 | CA2659969A1 Pyrazolo[1,5-a]pyrimidines, processes, uses and compositions |
| 02/07/2008 | CA2659511A1 Anticonvulsive pharmaceutical compositions |
| 02/07/2008 | CA2659477A1 Methods and pharmaceutical preparations for contributing to the treatment of chemotherapy-induced neuropathy |
| 02/07/2008 | CA2659376A1 2,4-diaminoquinazolines for spinal muscular atrophy |
| 02/07/2008 | CA2659148A1 Induction of analgesia in neuropathic pain |
| 02/07/2008 | CA2658799A1 N-(aminoheteroaryl)-1h-indole-2-carboxamide derivatives, and preparation and therapeutic application thereof |
| 02/07/2008 | CA2658552A1 Phenyl-prenyl-ether derivatives for the treatment of cognitive, neurodegenerative or neuronal diseases or disorders |
| 02/07/2008 | CA2652220A1 Adhesive preparation comprising methyl salicylate for percutaneous absorption |
| 02/07/2008 | CA2649044A1 Benzylphenyl glucopyranoside derivative |